AEMD · Aethlon Medical Inc · Executive Compensation
$4.84
-0.27 (-5.28%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$7.78M
Shares
1.61M
Volume · Nov 19
20.26K
Avg daily vol (3M)
2.52M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2026
| Executive | Role | Total |
|---|---|---|
| James B. Frakes | Chief Executive Officer and Chief Financial Officer | $826,922 |
| Steven P. LaRosa | Chief Medical Officer | $593,480 |
| Guy F. Cipriani | Former Senior Vice President, Chief Operating Officer | $211,250 |
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| James B. Frakes | Chief Executive Officer and Chief Financial Officer | $500,000 |
| Steven P. LaRosa | Chief Medical Officer | $480,000 |
| Guy F. Cipriani | Senior Vice President, Chief Operating Officer | $395,688 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Charles J. Fisher, Jr. | Jr., M.D. Former Chief Executive Officer | $505,332 |
| Charles Fisher | Jr., M.D. Former Chief Executive Officer | $505,332 |
| Steven P. LaRosa | Chief Medical Officer | $430,000 |
| James B. Frakes | Chief Executive Officer and Chief Financial Officer | $416,449 |
| Guy F. Cipriani | Senior Vice President, Chief Operating Officer | $378,064 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Charles J. Fisher, Jr. | Jr., M.D. Former Chief Executive Officer | $460,000 |
| Charles Fisher | Jr., M.D. Former Chief Executive Officer | $460,000 |
| Steven P. LaRosa | Chief Medical Officer | $430,000 |
| Guy F. Cipriani | Senior Vice President, Chief Operating Officer | $347,500 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Charles J. Fisher, Jr. | Jr., M.D. Chief Executive Officer | $2,477,896 |
| Charles Fisher | Jr., M.D. Chief Executive Officer | $2,477,896 |
| Steven P. LaRosa | Chief Medical Officer | $792,614 |
| Guy F. Cipriani | Senior Vice President, Chief Business Officer | $772,880 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Timothy C., Rodell | M.D., FCCP FORMER CHIEF EXECUTIVE OFFICER | $862,563 |
| James B. Frakes | CHIEF FINANCIAL OFFICER, SECRETARY AND SVP-FINANCE | $581,661 |
| Steven P. LaRosa | CHIEF MEDICAL OFFICER | $480,449 |
| Charles J. Fisher, Jr. | Jr., M.D. CHIEF EXECUTIVE OFFICER | $474,941 |
| Charles Fisher | Jr., M.D. CHIEF EXECUTIVE OFFICER | $474,941 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Timothy C., Rodell | M.D., FCCP FORMER CHIEF EXECUTIVE OFFICER | $595,000 |
| James B. Frakes | CHIEF FINANCIAL OFFICER, SECRETARY AND SVP-FINANCE | $354,750 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Timothy C., Rodell | M.D., FCCP CHIEF EXECUTIVE OFFICER | $729,138 |
| James B. Frakes | CHIEF FINANCIAL OFFICER, SECRETARY AND SVP-FINANCE | $285,833 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Chetan S. Shah, MD | director | Appointed | 2026-10-01 |
| Angela Rossetti | director | Appointed | 2026-10-01 |
| Nicolas Gikakis | director | Appointed | 2026-10-01 |
| James B. Frakes | director | Appointed | 2026-10-01 |
| Edward G. Broenniman | director | Appointed | 2026-10-01 |
| Angela Rossetti | director | Appointed | 2026-02-23 |
| Chetan S. Shah, MD | director | Appointed | 2026-02-23 |
| Nicolas Gikakis | director | Appointed | 2026-02-23 |
| James B. Frakes | director | Appointed | 2026-02-23 |
| Edward G. Broenniman | director | Appointed | 2026-02-23 |
| James B. Frakes | permanent Chief Executive Officer | Appointed | 2024-10-03 |
| Chetan S. Shah, MD | director | Appointed | 2024-10-02 |
| Angela Rossetti | director | Appointed | 2024-10-02 |
| James B. Frakes | director | Appointed | 2024-10-02 |
| Nicolas Gikakis | director | Appointed | 2024-10-02 |
| Edward G. Broenniman | director | Appointed | 2024-10-02 |
| Charles J. Fisher, Jr., M.D. | Director | Resigned | 2023-11-27 |
| Guy F. Cipriani | Senior Vice President and Chief Operating Officer | Appointed | 2023-11-13 |
| James B. Frakes | member of the Board of Directors | Appointed | 2023-11-13 |
| James B. Frakes | Interim Chief Executive Officer | Appointed | 2023-11-13 |
| Guy F. Cipriani | Director | Resigned | 2023-11-13 |
| Nicolas Gikakis | member of the Board | Appointed | 2023-07-06 |
| Chetan S. Shah, MD | member of the Board | Appointed | 2022-09-19 |
| Charles J. Fisher, Jr., MD | member of the Board | Appointed | 2022-09-19 |
| Guy F. Cipriani | member of the Board | Appointed | 2022-09-19 |
Leadership
- Charles Fisher CEO
- Charles J. Fisher, Jr., M.D. CEO
- James B. Frakes CEO, CFO, Board Member
- Timothy C. Rodell CEO
- Timothy C. Rodell, M.D., FCCP CEO
- Edward G. Broenniman Chairman
- Guy F. Cipriani COO, Board Member
- Angela Rossetti Board Member
- Charles J. Fisher, Jr., MD Board Member
- Chetan S. Shah Board Member
- Chetan S. Shah, MD Board Member
- Nicolas Gikakis Board Member
- Timothy C., Rodell Board Member
- Timothy Rodell Board Member
Key facts
CIK
882291
CUSIP
00808Y703
13F (30d)
16 filings
16 filers
Visit website
Investor relations